Windlas Biotech has allotted 28,990 equity shares under ESOS on 13 March 2026. Powered by Capital Market - Live News

Net profit of Windlas Biotech declined 3.72% to Rs 15.00 crore in the quarter ended December 2025 as against Rs 15.58 crore during the previous quarter ended December 2024. Sales rose 19.53% to Rs 233.10 crore in the quarter ended December 2025 as against Rs 195.02 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales233.10195.02 20 OPM %10.4612.63 - PBDT27.6727.28 1 PBT19.9720.34 -2 NP15.0015.58 -4 Powered by Capital Market - Live News

Windlas Biotech will hold a meeting of the Board of Directors of the Company on 5 February 2026.Powered by Capital Market - Live News

Net profit of Windlas Biotech rose 13.67% to Rs 17.80 crore in the quarter ended September 2025 as against Rs 15.66 crore during the previous quarter ended September 2024. Sales rose 18.93% to Rs 222.40 crore in the quarter ended September 2025 as against Rs 187.00 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales222.40187.00 19 OPM %12.8412.33 - PBDT31.1926.79 16 PBT23.5920.29 16 NP17.8015.66 14 Powered by Capital Market - Live News

Windlas Biotech will hold a meeting of the Board of Directors of the Company on 6 November 2025.Powered by Capital Market - Live News